One pill to rule cholesterol? new combo drug tested
NCT ID NCT07182383
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a single pill containing three cholesterol-lowering drugs (bempedoic acid, ezetimibe, and rosuvastatin) works the same as taking them separately. Fifty-eight healthy adults each received both the combination pill and the individual pills at different times. Researchers measured drug levels in the blood to see if the combination pill delivers the same amount of medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bempedoic acid, ezetimibe, and rosuvastatin
What this could lead to
If successful, this could lead to a simpler, single-pill option for lowering cholesterol, making it easier for patients to stick with their treatment.
What could go wrong
This is an early-stage study in healthy people, not patients. It only checks if the combined pill is absorbed similarly to separate pills, not if it actually reduces heart risks or is safe long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Porto, 4250-449, Portugal